Brian S. Andrews - Concepedia

Author

Brian S. Andrews

Also Known As

B Andrews, B S Andrews, B. Andrews, B. S. Andrews, B.S Andrews, BRIAN S. ANDREWS, Brian Andrews, Brian S Andrews, Brian S. Andrews, Bridie Andrews

Publications

4.9K

Citations

H-Index

100

Concepts

All Affiliations

University of California, Irvine University of California, Los Angeles University of Maryland, Baltimore Georgetown University Johns Hopkins University

About

Brian S. Andrews is an author at University of California, Irvine specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	3.1K
2	Allergy	7	7	251
3	Health Sciences	1	1	14
4	Public Health	1	1	26
5	Biology	1	1	26

Brian S. Andrews

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. Brian S. Andrews, Robert A. Eisenberg, Argyrios N. Theofilopoulos, The Journal of Experimental Medicine Immunopathological ManifestationsImmunologyPathologyDermatologyImmunotherapy	1978	1.6K
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases Christine Beeton, Heike Wulff, Nathan Standifer, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyImmune RegulationImmunologic MechanismT Cells	2006	525
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial Philip J. Clements, Daniel E. Fürst, Weng Kee Wong, Arthritis & Rheumatism	1999	330
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial Philip J. Clements, Eric L. Hurwitz, Weng Kee Wong, Arthritis & Rheumatism	2000	282
Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial Paul J. DeMarco, Michael H. Weisman, James R. Seibold, Arthritis & Rheumatism	2002	223
The Nature of Immune Complexes in Human Cancer Sera Argyrios N. Theofilopoulos, Brian S. Andrews, Marshall M. Urist, The Journal of Immunology Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyPathologyTherapeutic Vaccine	1977	202
Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study Dinesh Khanna, Daniel E. Furst, Ron D. Hays, Annals of the Rheumatic Diseases	2006	149
Antibodies to sm in patients with systemic lupus erythematosus. correlation of sm antibody titers with disease activity and other laboratory parameters Franc A. Barada, Brian S. Andrews, John S. Davisiv, Arthritis & Rheumatism	1981	113
Correlates of the disability index of the health assessment questionnaire: A measure of functional impairment in systemic sclerosis Philip J. Clements, Weng Kee Wong, Eric L. Hurwitz, Arthritis & Rheumatism	1999	113
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial Philip J. Clements, Weng Kee Wong, Eric L. Hurwitz, Arthritis & Rheumatism	2001	107

Page 1